Official UK procurement notice
Total Cellular Pathology Solution · ROCHE DIAGNOSTICS LIMITED for Regional Business Services Organisation Procurement and Logistics Service (Mar 2026)
Authority: Regional Business Services Organisation Procurement and Logistics Service
Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN06)
Awarded value£21,000,000published contract · exc. VAT
Awarded 12 Feb 2018
Awarded to ROCHE DIAGNOSTICS LIMITED
Contract term 1 yrends 1 Apr 2027 · starts 1 Apr 2026
What is being bought
Published requirement descriptionNo description was published on the notice. See the official documents.
CPV: Medical equipments, pharmaceuticals and personal care products
The lotProcurement structure
single lot · no lot value publishedLot #1Total Cellular Pathology Solution to the Belfast Health & Social Care Trust
Procedure terms & legal framework
From the official record- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 2 Mar 2026, 14:34 GMT
- Last source update
- 2 Mar 2026, 14:34 GMT
- Authority reference
454192- FTS notice number
2026/S 000-018516- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-065fccFind a Tender
How it was run
Official notice- Submission deadline
- —
Timeline
2 Mar 2026 → 1 Apr 2026 · 2 dates- Notice published235 days ago2 Mar 2026, 14:34 GMT
- Contract starts205 days ago1 Apr 2026, 00:00 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecastAwards 1
Awarded value £21,000,0001 contract exc. VAT
Contracts signed 1latest 12 Feb 2018
| Awarded to | Value | Date | Status |
|---|---|---|---|
| ROCHE DIAGNOSTICS LIMITED | £21,000,000 † | — | Awarded |
Contracts
Total Cellular Pathology Solution · ROCHE DIAGNOSTICS LIMITED
- Signed
- 12 Feb 2018
- Value
- £21,000,000
- Period
- 17 Jul 2018 – 31 Mar 2026
- Status
- active
- Change Due to delays in evaluation and award of a regional renewal tender to supersede this contact a 12 month extension (with potential for extension for up to a further 6 months) to the existing contract is being applied to allow for regional implementation and go live of the new replacement contract., Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee: A new regional tender renewal process has been delayed at evaluation and award stage (see notice number 029933-002 on www.find-tender.service.gov.uk). The delay in awarding this tender has the result that this current contract is to be extended, as indicated, to 1st April 2027 (with provision for up to 6 months further extension) to allow for award and subsequent regional implementation. This extension is being conducted in line with Reg 72(1)(b)(ii) of the 2015 PCR.
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Business Services Organsiation, Procurement Logistics ServiceMediation bodyReview bodyReview contact point
Bidders & participating suppliers
1 commercial party on the notice- Roche Diagnostics LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.